External validation of three diabetes prediction scores in a Spanish cohort: does adding high risk for depression improve the validation of the FINDRISC score (FINDRISC-MOOD)?
Salinero-Fort,M.,Mostaza-Prieto,J. M.,Lahoz-Rallo,C.,Cardenas-Valladolid,J.,Iriarte-Campo,V.,Estirado-Decabo,E.,Garcia-Iglesias,F.,Gonzalez-Alegre,T.,Fernandez-Puntero,B.,Cornejo-Del Rio,V. M.,Sanchez-Arroyo,V.,Sabin-Rodriguez,C.,Lopez-Lopez,S.,Gomez-Campelo,P.,Taulero-Escalera,B.,Rodriguez-Artalejo,F.,San Andres-Rebollo,F. J.,De Burgos-Lunar,C.,SPREDIA-2 Group,Laguna,Fernandez-Garcia,Montesano-Sanchez,Patron,Perez-Isla,Vicent,Vicente,Artola,Menendez,Beamud-Victoria,Dujovne-Kohan,Chico-Moraleja,Martin-Madrazo,deNicolas,Linde,Escolano,Sacristan,Otero,Perez,Ruiz,Diaz,Ena,Varela,Triguero,Garcia,Llorente,Laso,Garcia,Duenas,Zapata,Antuna,Lazaro,Rodriguez,Lucena,Hernandez,Vinals,Ogarrio,Manzano,Lopez,Pelaez,Candenas,Carrera,Rodriguez,Castellanos,Garcia,Pacheco
DOI: https://doi.org/10.1136/bmjopen-2023-083121
IF: 3.006
2024-06-08
BMJ Open
Abstract:Objectives To evaluate the external validity of the FINDRISC, DESIR and ADA risk scores for the prediction of diabetes in a Spanish population aged >45 years and to test the possible improvement of FINDRISC by adding a new variable of high risk of depression when Patient Health Questionnaire-9 (PHQ-9) questionnaire score ≥10 (FINDRISC-MOOD). Design Prospective population-based cohort study. Setting 10 primary healthcare centres in the north of the city of Madrid (Spain). Participants A total of 1242 participants without a history of diabetes and with 2-hour oral glucose tolerance test (OGTT) plasma glucose <200 mg/dL (<11.1 mmol/L) were followed up for 7.3 years (median) using their electronic health records (EHRs) and telephone contact. Primary and secondary outcome measures Diabetes risk scores (FINDRISC, DESIR, ADA), PHQ-9 questionnaire and 2-hour-OGTT were measured at baseline. Incident diabetes was defined as treatment for diabetes, fasting plasma glucose ≥126 mg/dL (≥7.0 mmol/L), new EHR diagnosis or self-reported diagnosis. External validation was performed according to optimal cut-off, sensitivity, specificity and Youden Index. Comparison between diabetes risk scores, including FINDRISC-MOOD (original FINDRISC score plus five points if PHQ-9 ≥10), was measured by area under the receiver operating characteristic curve (AUROC). Results During follow-up, 104 (8.4%; 95% CI, 6.8 to 9.9) participants developed diabetes and 185 had a PHQ-9 score ≥10. The AUROC values were 0.70 (95% CI, 0.67 to 0.72) for FINDRISC-MOOD and 0.68 (95% CI, 0.65 to 0.71) for the original FINDRISC. The AUROCs for DESIR and ADA were 0.66 (95% CI, 0.63 to 0.68) and 0.66 (95% CI, 0.63 to 0.69), respectively. There were no significant differences in AUROC between FINDRISC-MOOD and the other scores. Conclusions The results of FINDRISC-MOOD were like those of the other risk scores and do not allow it to be recommended for clinical use.
medicine, general & internal